STOCK TITAN

Artivion to Host Investor & Analyst Day on March 23, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Artivion, a leader in cardiac and vascular surgery, announced an Investor & Analyst Day set for March 23, 2022, in New York City. The event, starting at 9:00 AM ET, will feature management presentations and discussions from cardiac and vascular surgeons focusing on aortic disease. Attendees can expect insights into Artivion's product portfolio, market strategies, and financial performance. A live webcast will be available on Artivion’s website, with archived access post-event. Registration for in-person attendance is required by March 18, 2022.

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

ATLANTA, March 9, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will host an Investor & Analyst Day in New York City on Wednesday, March 23, 2022 at 9:00 AM ET. The event will include presentations by members of management and cardiac and vascular surgeons who focus on treating patients with aortic disease. The presentations will cover Artivion's product portfolio, key addressable markets, growth strategy, and operational and financial performance.

A live webcast of presentations and Q&A sessions will be accessible through Artivion's website, www.artivion.com, on the Investors page. Click here to access the webcast directly. An archived copy of the webcast will be available on the same website. Please note that Q&A will be conducted live, in-person only following the formal presentations.

In-person attendance at the event requires advanced registration. Please email Laine Morgan at laine@gilmartinir.com by March 18, 2022 for further information.

About Artivion
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stents and stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:




Artivion

Gilmartin Group LLC

D. Ashley Lee

Executive Vice President &

Chief Financial Officer
Phone: 770-419-3355

Brian Johnston / Lynn Lewis

Phone: 332-895-3222

investors@artivion.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-host-investor--analyst-day-on-march-23-2022-301498435.html

SOURCE Artivion, Inc.

FAQ

What is the date and time of Artivion's Investor & Analyst Day?

Artivion's Investor & Analyst Day is on March 23, 2022, at 9:00 AM ET.

Where will Artivion's Investor & Analyst Day be held?

The event will take place in New York City.

How can I access the live webcast of the event?

The live webcast can be accessed on Artivion's website under the Investors page.

What topics will be discussed at Artivion's Investor & Analyst Day?

The event will cover Artivion's product portfolio, key markets, growth strategies, and financial performance.

Is registration required to attend Artivion's Investor & Analyst Day in person?

Yes, in-person attendance requires advance registration by March 18, 2022.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

1.45B
37.67M
5.01%
98.51%
2.89%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW